Admission Date:  [**2117-3-4**]              Discharge Date:   [**2117-3-10**]  Date of Birth:  [**2053-12-5**]             Sex:   M  Service: MEDICINE  Allergies: Penicillins / Aspirin / Codeine  Attending:[**First Name3 (LF) 1990**] Chief Complaint: abdominal pain, fever  Major Surgical or Invasive Procedure: ERCP [**3-5**] at OSH:  percutaneous biliary tube placement, cholecystectomy, Rt sided AKA  History of Present Illness: 63M with PVD, EtOH and cocaine abuse, admitted to [**Hospital **] Hospital on [**2117-2-22**] with septic shock and E.coli bacteremia, now transferred to [**Hospital1 18**] for further workup and potential ERCP.
Blood cultures grew E.coli bacteremia and he developed septic shock and was admitted to the ICU.
He also had NSTEMI in setting of his sepsis with peak troponin 37.88 on [**2-24**].
Echo showed EF 25-30% with severe global LV HK.
Post op noted to have increasing amylase (to 551) and lipase (to 288).
Pertinent Results: [**2117-3-4**] 09:18PM   GLUCOSE-96 UREA N-20 CREAT-0.5 SODIUM-138 POTASSIUM-4.1 CHLORIDE-106 TOTAL CO2-22 ANION GAP-14 [**2117-3-4**] 09:18PM   estGFR-Using this [**2117-3-4**] 09:18PM   ALT(SGPT)-192* AST(SGOT)-92* LD(LDH)-211 CK(CPK)-130 ALK PHOS-263* AMYLASE-516* TOT BILI-0.7 [**2117-3-4**] 09:18PM   LIPASE-241* [**2117-3-4**] 09:18PM   CK-MB-2 cTropnT-0.16* [**2117-3-4**] 09:18PM   IRON-65 [**2117-3-4**] 09:18PM   ALBUMIN-3.4* CALCIUM-8.9 PHOSPHATE-4.1 MAGNESIUM-2.0 [**2117-3-4**] 09:18PM   calTIBC-313 FERRITIN-314 TRF-241 [**2117-3-4**] 09:18PM   VIT B12-GREATER TH FOLATE-15.8 [**2117-3-4**] 09:18PM   TRIGLYCER-131 [**2117-3-4**] 09:18PM   TSH-1.7 [**2117-3-4**] 09:18PM   HBsAg-NEGATIVE HBs Ab-NEGATIVE HBc Ab-NEGATIVE HAV Ab-POSITIVE [**2117-3-4**] 09:18PM   HCV Ab-POSITIVE* [**2117-3-4**] 09:18PM   WBC-11.9* RBC-4.06* HGB-11.2* HCT-33.5* MCV-83 MCH-27.7 MCHC-33.5 RDW-14.8 [**2117-3-4**] 09:18PM   NEUTS-69.4 LYMPHS-22.2 MONOS-5.4 EOS-2.3 BASOS-0.7 [**2117-3-4**] 09:18PM   PLT COUNT-647* [**2117-3-4**] 09:18PM   PT-12.9 PTT-23.6 INR(PT)-1.1  on dishcarge from the [**Hospital1 **], pt.s platelet count was 1,049,000.
If platelet count is continuing to rise, pt.
will need evaluation by hematology to rule out underlying ET or PV by peripheral smear review and or bone marrow biopsy.
: [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 4427**], MD     Assisting Nurse(s)/ Other Personnel: [**First Name11 (Name Pattern1) **] [**Initials (NamePattern4) **] [**Last Name (NamePattern4) 52485**], RN Birth Date: [**2053-12-5**] (63 years) Instrument: TJF-160VF ([**Telephone/Fax (5) 86102**] Indications: A level 4 consult was performed Elevated LFTs s/p complicated cholecystectomy, and abnormal CT scan showing a dilated CBD and fluid in the gallbladder fossa.
Medications: Cetacaine topical spray Monitored anesthesia care  Procedure: The procedure, indications, preparation and potential complications were explained to the patient, who indicated his understanding and signed the corresponding consent forms.
A physical exam was performed.
The patient was placed in the supine position and an endoscope was introduced through the mouth and advanced under direct visualization until the third part of the duodenum was reached.
Findings: Esophagus: Limited exam of the esophagus was normal Stomach: Limited exam of the stomach was normal Duodenum: Limited exam of the duodenum was normal Major Papilla: Normal major papilla Cannulation:  Cannulation of the pancreatic duct was performed with a sphincterotome after a guidewire was placed in order to place a PD stent to facilitate biliary cannulation.
Contrast medium was injected resulting in partial opacification.
Cannulation of the biliary duct was performed with a sphincterotome after a guidewire was placed.
Contrast medium was injected resulting in complete opacification.
Cannulation of the pancreatic duct was performed with a sphincterotome after a guidewire was placed in order to place a PD stent to facilitate biliary cannulation.
Contrast medium was injected resulting in partial opacification.
Cannulation of the biliary duct was performed with a sphincterotome after a guidewire was placed.
Contrast medium was injected resulting in complete opacification.
Recommend MRCP to evaluate his dilated pancreatic duct.
Additional notes: The procedure was performed by Dr. [**Last Name (STitle) **] and the GI fellow.
_________________________________ [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern1) **], MD (attending) _________________________________ [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **], MD (fellow) Case documentation started on [**2117-3-5**] 3:22:40 PM Patient: [**Known firstname **] [**Last Name (NamePattern1) 86101**] ([**Numeric Identifier **])   Brief Hospital Course: 63M with PVD, EtOH abuse, presents with septic shock from presumed biliary source, now transferred to [**Hospital1 18**] for consideration of ERCP and further management of abnormal LFTs and lipase.
found to have hcv - ab positive and viral load of:  [**2117-3-5**] 5:41 am IMMUNOLOGY       CHEM S# [**Serial Number 24032**]D QUANTITATION BEYOND 850,000 IU/ML ADDED [**3-5**].
His cultures obtained here remained negative.
ECG with inferior Q waves and poor transition - present on ECGs early this admission though unclear exactly how old.
CT abdomen obtained and seemed to show graft thrombosis.
Polyethylene Glycol 3350 17 gram/dose Powder Sig: Seventeen (17) gram PO DAILY (Daily) as needed for constipation.
therapy completed, surveillance cultures no growth to date) s/p open ccy s/p rt LE BKA amputation Deconditioning HCV infection, chronic Ongoing polysubstance abuse and tobacco use (alcohol, cocaine)  Discharge Condition: Mental Status: Clear and coherent Level of Consciousness: Alert and interactive Activity Status: Ambulatory - requires assistance or aid (walker or cane)  Discharge Instructions: See below  Followup Instructions: Primary MD: ([**Doctor First Name **] J.
